Skip to main content

Animations

MJFF Publications

591 - 600 of 9033 Results
Title
Year
  • Year
  • 2020
  • 2017
  • 2019
  • 2017
  • 2014
  • 2016
  • 2014
  • 2016
  • 2016
  • 2021
  • Summary Details
    RESTRICTED
    Title: Clinical and Imaging Markers of Prodromal Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00395
    Citation Count: 91
  • Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?
    2017
    Summary Details
    RESTRICTED
    Title: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disorders
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.phrs.2019.104343
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Striatal cholinergic interneurons and Parkinson's disease
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13638
    Citation Count: 70
  • Summary Details
    RESTRICTED
    Title: Blood-based biomarkers for Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1353-8020(13)70025-7
    Citation Count: 123
  • Summary Details
    RESTRICTED
    Title: Biomarkers in Parkinson's disease: Advances and strategies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048
    Citation Count: 133
  • Summary Details
    RESTRICTED
    Title: Oxidized DJ-1 as a possible biomarker of Parkinson’s disease
    Journal Name: Journal of Clinical Biochemistry and Nutrition
    Publisher: The Society for Free Radical Research Japan
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3164/jcbn.13-108
    Citation Count: 61
  • Leucine‐rich repeat kinase 2 and Parkinson's disease
    2016
    Summary Details
    RESTRICTED
    Title: Leucine‐rich repeat kinase 2 and Parkinson's disease
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201600092
    Citation Count: 23
  • Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein
    2016
    Summary Details
    RESTRICTED
    Title: Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12299
    Citation Count: 66
  • Summary Details
    RESTRICTED
    Title: Intersection of immunometabolism and immunosenescence during aging
    Journal Name: Current Opinion in Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.coph.2021.01.003
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.